Should We Shorten or Lengthen Postpolypectomy Surveillance Intervals?

  1. Adeyinka O. Laiyemo, MD, MPH;
  2. Elaine Lanza, PhD; and
  3. Arthur Schatzkin, MD, DrPH
  1. From National Cancer Institute, Bethesda, MD 20892.

    IN RESPONSE:

    We agree with Drs. Rex and Winawer that a single study is unlikely to be definitive, especially when, as they suggest, variability in clinician judgment influences the identified predictors of higher risk for advanced adenoma.

    We did not, however, recommend shortening the interval of …

    « Previous | Next Article »Table of Contents